Articles citing this paper
Structural reassignment of a dibenz[b,f][1,4]oxazepin-11(10H)-one with potent antigiardial activity
Andrew G. Riches
A * , Christopher J. S. Hart B C , Matthieu Schmit A , Emmanuel A. Debele A , Snigdha Tiash B , Erin Clapper B , Tina S. Skinner-Adams B * and John H. Ryan A
+ Author Affiliations
- Author Affiliations
A CSIRO Manufacturing, Ian Wark Laboratory, Bayview Avenue, Clayton, Vic. 3168, Australia.
B Griffith Institute for Drug Discovery, Griffith University, Nathan, Qld 4111, Australia.
C Present address: Department of Microbiology and Molecular Genetics, University of California Davis, CA 95616, USA.
* Correspondence to: andrew.riches@csiro.au, t.skinner-adams@griffith.edu.au
Handling Editor: Craig Hutton
Australian Journal of Chemistry 75(10) 839-845 https://doi.org/10.1071/CH22184
Submitted: 23 August 2022 Accepted: 14 October 2022 Published: 10 November 2022
2 articles found in Crossref database.
Efficient Metal-Free Oxidative C–H Amination for Accessing Dibenzoxazepinones via μ-Oxo Hypervalent Iodine Catalysis
Sasa Hirotaka,
Hamatani Syotaro,
Hirashima Mayu,
Takenaga Naoko,
Hanasaki Tomonori, Dohi Toshifumi
Chemistry. 2023 5(4). p.2155
A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery
Hart Christopher J. S.,
Riches Andrew G.,
Tiash Snigdha,
Clapper Erin,
Ramu Soumya,
Zuegg Johannes,
Ryan John H., Skinner-Adams Tina S.
Biomedicines. 2022 10(12). p.3182
